| DSTN |
DSTN, ACTDP, DSN: Destrin |
MAPKAPK5 |
IPI00160672 |
6.405 |
Evidence |
|
| EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
6.405 |
Evidence |
|
| EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
ECM1 |
ECM1: Extracellular matrix protein 1 precursor |
6.405 |
Evidence |
|
| FXR2 |
FXR2, FMR1L2: Fragile X mental retardation syndrome-related protein 2 |
UACA |
UACA, KIAA1561: Uveal autoantigen with coiled-coil domains and ankyrin repeats |
6.405 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
STAP2 |
Uncharacterized protein ENSP00000317912 |
6.405 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
STAP2 |
Uncharacterized protein ENSP00000317912 |
6.405 |
Evidence |
|
| SNCA |
SNCA, NACP, PARK1: Alpha-synuclein |
IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
6.405 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
STAP2 |
Uncharacterized protein ENSP00000317912 |
6.405 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
C9orf88 |
IPI00647286 |
6.405 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
PKP4 |
PKP4: Plakophilin-4 |
6.405 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
YWHAG |
YWHAG: 14-3-3 protein gamma |
6.405 |
Evidence |
|
| PSMC2 |
PSMC2, MSS1: 26S protease regulatory subunit 7 |
MATK |
|
6.405 |
Evidence |
|
| S100A11 |
MLN70, S100A11, S100C: Protein S100-A11 |
CFL2 |
CFL2: Cofilin-2 |
6.405 |
Evidence |
|
| NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
6.405 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
ZNF295 |
ZNF295, KIAA1227, ZBTB21: Zinc finger protein 295 |
6.405 |
Evidence |
|
| MCM3 |
MCM3: DNA replication licensing factor MCM3 |
BID |
BID: BH3-interacting domain death agonist |
6.405 |
Evidence |
|
| EEF1B2 |
EEF1B2, EEF1B, EF1B: Elongation factor 1-beta |
YWHAG |
YWHAG: 14-3-3 protein gamma |
6.405 |
Evidence |
|
| EEF1B2 |
EEF1B2, EEF1B, EF1B: Elongation factor 1-beta |
CDC42 |
IPI00016786 |
6.405 |
Evidence |
|
| EEF1B2 |
EEF1B2, EEF1B, EF1B: Elongation factor 1-beta |
SNCA |
SNCA, NACP, PARK1: Alpha-synuclein |
6.405 |
Evidence |
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
C14orf151 |
C14orf151: Uncharacterized protein C14orf151 (Fragment) |
6.405 |
Evidence |
|
| EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
ILF3 |
ILF3, DRBF, MPHOSPH4, NF90: Interleukin enhancer-binding factor 3 |
6.405 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
CFL2 |
CFL2: Cofilin-2 |
6.405 |
Evidence |
|
| PTPRA |
IPI00163420 |
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
6.405 |
Evidence |
|
| JUNB |
JUNB: Transcription factor jun-B |
PTBP1 |
PTBP1: Polypyrimidine tract binding protein 1 |
6.405 |
Evidence |
|
| LOC643930 |
CCL3L1, D17S1718, G0S19-2, SCYA3L1: Small-inducible cytokine A3-like 1 precursor |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
6.405 |
Evidence |
|